Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery
Clinical trial NCT07734766 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07734766
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2029-03-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.